Nutex Health, Inc. (NASDAQ: NUTX) Stock Competitors & Peer Comparison
See NUTX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NUTX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUTX | $187.42 | +0.33% | 1.3B | 14.48 | $12.94 | N/A |
| HCA | $404.68 | -1.71% | 87.6B | 13.97 | $28.96 | +0.74% |
| THC | $267.90 | +0.32% | 21.6B | 15.54 | $17.24 | N/A |
| FMS | $23.77 | +0.59% | 12.8B | 8.93 | $2.66 | +3.64% |
| EHC | $123.59 | +0.03% | 12.3B | 21.16 | $5.84 | +0.61% |
| BTSGU | $203.17 | +1.04% | 12B | 184.06 | $1.11 | N/A |
| DVA | $180.06 | -0.79% | 11.5B | 14.00 | $12.80 | N/A |
| ENSG | $181.65 | -0.13% | 10.6B | 26.33 | $6.90 | +0.14% |
| UHS | $170.02 | -0.70% | 10.3B | 7.54 | $22.54 | +0.47% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
NUTX vs HCA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, HCA has a market cap of 87.6B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while HCA trades at $404.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas HCA's P/E ratio is 13.97. In terms of profitability, NUTX's ROE is +0.52%, compared to HCA's ROE of -1.13%. Regarding short-term risk, NUTX is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
NUTX vs THC Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, THC has a market cap of 21.6B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while THC trades at $267.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas THC's P/E ratio is 15.54. In terms of profitability, NUTX's ROE is +0.52%, compared to THC's ROE of +0.51%. Regarding short-term risk, NUTX is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
NUTX vs FMS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, FMS has a market cap of 12.8B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while FMS trades at $23.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas FMS's P/E ratio is 8.93. In terms of profitability, NUTX's ROE is +0.52%, compared to FMS's ROE of +0.07%. Regarding short-term risk, NUTX is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
NUTX vs EHC Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, EHC has a market cap of 12.3B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while EHC trades at $123.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas EHC's P/E ratio is 21.16. In terms of profitability, NUTX's ROE is +0.52%, compared to EHC's ROE of +0.25%. Regarding short-term risk, NUTX is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
NUTX vs BTSGU Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, BTSGU has a market cap of 12B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while BTSGU trades at $203.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas BTSGU's P/E ratio is 184.06. In terms of profitability, NUTX's ROE is +0.52%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, NUTX is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
NUTX vs DVA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, DVA has a market cap of 11.5B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while DVA trades at $180.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas DVA's P/E ratio is 14.00. In terms of profitability, NUTX's ROE is +0.52%, compared to DVA's ROE of -1.24%. Regarding short-term risk, NUTX is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
NUTX vs ENSG Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ENSG trades at $181.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ENSG's P/E ratio is 26.33. In terms of profitability, NUTX's ROE is +0.52%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, NUTX is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
NUTX vs UHS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while UHS trades at $170.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas UHS's P/E ratio is 7.54. In terms of profitability, NUTX's ROE is +0.52%, compared to UHS's ROE of +0.21%. Regarding short-term risk, NUTX is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
NUTX vs OSH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas OSH's P/E ratio is -17.65. In terms of profitability, NUTX's ROE is +0.52%, compared to OSH's ROE of +4.64%. Regarding short-term risk, NUTX is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
NUTX vs PACS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, PACS has a market cap of 7B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while PACS trades at $44.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas PACS's P/E ratio is 23.51. In terms of profitability, NUTX's ROE is +0.52%, compared to PACS's ROE of +0.27%. Regarding short-term risk, NUTX is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
NUTX vs CHE Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CHE has a market cap of 7B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CHE trades at $532.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CHE's P/E ratio is 24.67. In terms of profitability, NUTX's ROE is +0.52%, compared to CHE's ROE of +0.29%. Regarding short-term risk, NUTX is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
NUTX vs LHCG Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas LHCG's P/E ratio is 82.83. In terms of profitability, NUTX's ROE is +0.52%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, NUTX is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
NUTX vs LFST Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, LFST has a market cap of 4.8B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while LFST trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas LFST's P/E ratio is 93.55. In terms of profitability, NUTX's ROE is +0.52%, compared to LFST's ROE of +0.03%. Regarding short-term risk, NUTX is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
NUTX vs CON Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CON trades at $35.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CON's P/E ratio is 24.59. In terms of profitability, NUTX's ROE is +0.52%, compared to CON's ROE of +0.47%. Regarding short-term risk, NUTX is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
NUTX vs OPCH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while OPCH trades at $23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas OPCH's P/E ratio is 13.92. In terms of profitability, NUTX's ROE is +0.52%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, NUTX is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
NUTX vs NHC Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while NHC trades at $223.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas NHC's P/E ratio is 28.34. In terms of profitability, NUTX's ROE is +0.52%, compared to NHC's ROE of +0.13%. Regarding short-term risk, NUTX is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
NUTX vs AMED Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AMED's P/E ratio is 39.30. In terms of profitability, NUTX's ROE is +0.52%, compared to AMED's ROE of +0.11%. Regarding short-term risk, NUTX is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMED's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
NUTX vs BKD Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, BKD has a market cap of 3B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while BKD trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas BKD's P/E ratio is -21.77. In terms of profitability, NUTX's ROE is +0.52%, compared to BKD's ROE of +4.06%. Regarding short-term risk, NUTX is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
NUTX vs ACHC Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ACHC has a market cap of 2.9B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ACHC trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ACHC's P/E ratio is 15.49. In terms of profitability, NUTX's ROE is +0.52%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, NUTX is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
NUTX vs AVAH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AVAH trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AVAH's P/E ratio is 18.12. In terms of profitability, NUTX's ROE is +0.52%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, NUTX is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
NUTX vs GRDN Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while GRDN trades at $38.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas GRDN's P/E ratio is 33.72. In terms of profitability, NUTX's ROE is +0.52%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, NUTX is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
NUTX vs MD Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while MD trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas MD's P/E ratio is 11.88. In terms of profitability, NUTX's ROE is +0.52%, compared to MD's ROE of +0.20%. Regarding short-term risk, NUTX is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
NUTX vs ADUS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ADUS trades at $116.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ADUS's P/E ratio is 17.37. In terms of profitability, NUTX's ROE is +0.52%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, NUTX is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
NUTX vs SEM Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas SEM's P/E ratio is 15.43. In terms of profitability, NUTX's ROE is +0.52%, compared to SEM's ROE of +0.08%. Regarding short-term risk, NUTX is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
NUTX vs ASTH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ASTH trades at $40.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ASTH's P/E ratio is 39.24. In terms of profitability, NUTX's ROE is +0.52%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, NUTX is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
NUTX vs SGRY Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while SGRY trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas SGRY's P/E ratio is 38.54. In terms of profitability, NUTX's ROE is +0.52%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, NUTX is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SGRY's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
NUTX vs SNDA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while SNDA trades at $39.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas SNDA's P/E ratio is -7.25. In terms of profitability, NUTX's ROE is +0.52%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, NUTX is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
NUTX vs AMEH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AMEH's P/E ratio is 39.25. In terms of profitability, NUTX's ROE is +0.52%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, NUTX is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
NUTX vs AGL Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AGL trades at $96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AGL's P/E ratio is -10.83. In terms of profitability, NUTX's ROE is +0.52%, compared to AGL's ROE of -1.19%. Regarding short-term risk, NUTX is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
NUTX vs ARDT Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ARDT's P/E ratio is 8.81. In terms of profitability, NUTX's ROE is +0.52%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, NUTX is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
NUTX vs HCSG Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while HCSG trades at $21.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas HCSG's P/E ratio is 17.27. In terms of profitability, NUTX's ROE is +0.52%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, NUTX is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
NUTX vs INNV Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, INNV has a market cap of 1.4B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas INNV's P/E ratio is -117.89. In terms of profitability, NUTX's ROE is +0.52%, compared to INNV's ROE of -0.09%. Regarding short-term risk, NUTX is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
NUTX vs PNTG Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while PNTG trades at $39.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas PNTG's P/E ratio is 29.79. In terms of profitability, NUTX's ROE is +0.52%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, NUTX is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
NUTX vs AMN Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AMN trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AMN's P/E ratio is 11.44. In terms of profitability, NUTX's ROE is +0.52%, compared to AMN's ROE of +0.15%. Regarding short-term risk, NUTX is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AMN's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
NUTX vs USPH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while USPH trades at $81.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas USPH's P/E ratio is 31.94. In terms of profitability, NUTX's ROE is +0.52%, compared to USPH's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
NUTX vs BKDT Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas BKDT's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, NUTX is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
NUTX vs TALK Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TALK's P/E ratio is 774.34. In terms of profitability, NUTX's ROE is +0.52%, compared to TALK's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
NUTX vs FSHCX Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, FSHCX has a market cap of 877.3M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while FSHCX trades at $116.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas FSHCX's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to FSHCX's ROE of N/A. Regarding short-term risk, NUTX is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
NUTX vs GMRS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, GMRS has a market cap of 718.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while GMRS trades at $13.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas GMRS's P/E ratio is 5.92. In terms of profitability, NUTX's ROE is +0.52%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, NUTX is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
NUTX vs EHAB Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas EHAB's P/E ratio is -197.14. In terms of profitability, NUTX's ROE is +0.52%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, NUTX is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
NUTX vs STLN Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while STLN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas STLN's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to STLN's ROE of +2.10%. Regarding short-term risk, NUTX is more volatile compared to STLN. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
NUTX vs TOI Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TOI's P/E ratio is -14.25. In terms of profitability, NUTX's ROE is +0.52%, compared to TOI's ROE of +2.10%. Regarding short-term risk, NUTX is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
NUTX vs SRTA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, SRTA has a market cap of 510.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while SRTA trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas SRTA's P/E ratio is -27.81. In terms of profitability, NUTX's ROE is +0.52%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, NUTX is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
NUTX vs MCTA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas MCTA's P/E ratio is 419.36. In terms of profitability, NUTX's ROE is +0.52%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, NUTX is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
NUTX vs CYH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CYH has a market cap of 419.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CYH trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CYH's P/E ratio is 4.08. In terms of profitability, NUTX's ROE is +0.52%, compared to CYH's ROE of +0.21%. Regarding short-term risk, NUTX is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
NUTX vs AUNA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AUNA has a market cap of 388.6M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AUNA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AUNA's P/E ratio is 4.73. In terms of profitability, NUTX's ROE is +0.52%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, NUTX is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
NUTX vs VMD Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, VMD has a market cap of 350.4M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while VMD trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas VMD's P/E ratio is 25.56. In terms of profitability, NUTX's ROE is +0.52%, compared to VMD's ROE of +0.10%. Regarding short-term risk, NUTX is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check VMD's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
NUTX vs AIRS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AIRS has a market cap of 242M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AIRS trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AIRS's P/E ratio is -114.33. In terms of profitability, NUTX's ROE is +0.52%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, NUTX is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
NUTX vs CSU Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CSU's P/E ratio is 0.67. In terms of profitability, NUTX's ROE is +0.52%, compared to CSU's ROE of -0.33%. Regarding short-term risk, NUTX is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
NUTX vs JYNT Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, JYNT has a market cap of 120.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while JYNT trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas JYNT's P/E ratio is 84.50. In terms of profitability, NUTX's ROE is +0.52%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, NUTX is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check JYNT's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
NUTX vs PARK Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, PARK has a market cap of 103.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while PARK trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas PARK's P/E ratio is 31.11. In terms of profitability, NUTX's ROE is +0.52%, compared to PARK's ROE of -0.00%. Regarding short-term risk, NUTX is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
NUTX vs FVE Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas FVE's P/E ratio is -5.64. In terms of profitability, NUTX's ROE is +0.52%, compared to FVE's ROE of -0.15%. Regarding short-term risk, NUTX is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
NUTX vs KDLYW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas KDLYW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, NUTX is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
NUTX vs BTMD Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, BTMD has a market cap of 64.8M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while BTMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas BTMD's P/E ratio is 13.36. In terms of profitability, NUTX's ROE is +0.52%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, NUTX is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
NUTX vs DCGO Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, DCGO has a market cap of 64.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while DCGO trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas DCGO's P/E ratio is -0.75. In terms of profitability, NUTX's ROE is +0.52%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, NUTX is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
NUTX vs ALR Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ALR's P/E ratio is -1.11. In terms of profitability, NUTX's ROE is +0.52%, compared to ALR's ROE of -0.15%. Regarding short-term risk, NUTX is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check ALR's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
NUTX vs PIII Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, PIII has a market cap of 35M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while PIII trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas PIII's P/E ratio is -0.27. In terms of profitability, NUTX's ROE is +0.52%, compared to PIII's ROE of +1.61%. Regarding short-term risk, NUTX is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
NUTX vs IMAC Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas IMAC's P/E ratio is -2.27. In terms of profitability, NUTX's ROE is +0.52%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
NUTX vs CCEL Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CCEL has a market cap of 32.3M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CCEL trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CCEL's P/E ratio is -13.33. In terms of profitability, NUTX's ROE is +0.52%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, NUTX is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check CCEL's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
NUTX vs EUDA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while EUDA trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas EUDA's P/E ratio is -26.63. In terms of profitability, NUTX's ROE is +0.52%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, NUTX is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
NUTX vs CANO-WT Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, NUTX is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
NUTX vs AIH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AIH's P/E ratio is -2.78. In terms of profitability, NUTX's ROE is +0.52%, compared to AIH's ROE of +1.16%. Regarding short-term risk, NUTX is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
NUTX vs CANO Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CANO's P/E ratio is -0.01. In terms of profitability, NUTX's ROE is +0.52%, compared to CANO's ROE of -1.49%. Regarding short-term risk, NUTX is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
NUTX vs FPCG Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas FPCG's P/E ratio is 0.09. In terms of profitability, NUTX's ROE is +0.52%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, NUTX is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
NUTX vs AMS Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AMS trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AMS's P/E ratio is -6.74. In terms of profitability, NUTX's ROE is +0.52%, compared to AMS's ROE of -0.07%. Regarding short-term risk, NUTX is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
NUTX vs FTRP Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas FTRP's P/E ratio is -1.22. In terms of profitability, NUTX's ROE is +0.52%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, NUTX is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
NUTX vs BMGL Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, BMGL has a market cap of 8.6M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while BMGL trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas BMGL's P/E ratio is -1.04. In terms of profitability, NUTX's ROE is +0.52%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, NUTX is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
NUTX vs XWEL Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, XWEL has a market cap of 7.9M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while XWEL trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas XWEL's P/E ratio is -0.18. In terms of profitability, NUTX's ROE is +0.52%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, NUTX is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check XWEL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
NUTX vs AIDX Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AIDX has a market cap of 6.7M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AIDX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AIDX's P/E ratio is -1.04. In terms of profitability, NUTX's ROE is +0.52%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, NUTX is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
NUTX vs MODV Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas MODV's P/E ratio is -0.06. In terms of profitability, NUTX's ROE is +0.52%, compared to MODV's ROE of +1.36%. Regarding short-term risk, NUTX is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
NUTX vs GBNH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas GBNH's P/E ratio is -0.06. In terms of profitability, NUTX's ROE is +0.52%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, NUTX is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
NUTX vs RHE Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas RHE's P/E ratio is -1.79. In terms of profitability, NUTX's ROE is +0.52%, compared to RHE's ROE of -1.31%. Regarding short-term risk, NUTX is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
NUTX vs RHE-PA Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, NUTX's ROE is +0.52%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, NUTX is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check RHE-PA's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
NUTX vs STLNW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, STLNW has a market cap of 5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas STLNW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to STLNW's ROE of N/A. Regarding short-term risk, NUTX is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check STLNW's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
NUTX vs TOIIW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, NUTX's ROE is +0.52%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, NUTX is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
NUTX vs IMACW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas IMACW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, NUTX is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
NUTX vs NAKAW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, NUTX's ROE is +0.52%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, NUTX is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
NUTX vs CCM Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, CCM has a market cap of 690.2K. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while CCM trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas CCM's P/E ratio is -0.32. In terms of profitability, NUTX's ROE is +0.52%, compared to CCM's ROE of +0.06%. Regarding short-term risk, NUTX is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
NUTX vs NIVF Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, NIVF has a market cap of 109.4K. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while NIVF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas NIVF's P/E ratio is 0.28. In terms of profitability, NUTX's ROE is +0.52%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, NUTX is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
NUTX vs MNDR Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, MNDR has a market cap of 42.3K. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while MNDR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas MNDR's P/E ratio is -0.04. In terms of profitability, NUTX's ROE is +0.52%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, NUTX is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
NUTX vs NIVFW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, NUTX's ROE is +0.52%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, NUTX is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
NUTX vs TALKW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TALKW's P/E ratio is 0.00. In terms of profitability, NUTX's ROE is +0.52%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, NUTX is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
NUTX vs TLMD Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TLMD's P/E ratio is -1.60. In terms of profitability, NUTX's ROE is +0.52%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, NUTX is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TLMD's competition here
New Frontier Health Corporation (NYSE: NFH)
NUTX vs NFH Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, NFH has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas NFH's P/E ratio is -19.75. In terms of profitability, NUTX's ROE is +0.52%, compared to NFH's ROE of -0.06%. Regarding short-term risk, NUTX is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check NFH's competition here
DocGo Inc. (NASDAQ: DCGOW)
NUTX vs DCGOW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas DCGOW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, NUTX is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DCGOW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
NUTX vs DVCR Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas DVCR's P/E ratio is 28.34. In terms of profitability, NUTX's ROE is +0.52%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, NUTX is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check DVCR's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
NUTX vs TVTY Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TVTY's P/E ratio is 19.06. In terms of profitability, NUTX's ROE is +0.52%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, NUTX is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TVTY's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
NUTX vs TLMDW Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas TLMDW's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, NUTX is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
NUTX vs HNGR Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas HNGR's P/E ratio is 19.71. In terms of profitability, NUTX's ROE is +0.52%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, NUTX is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
NUTX vs ATIP-WT Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, NUTX is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
NUTX vs SLHGP Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, NUTX's ROE is +0.52%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, NUTX is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
NUTX vs SLHG Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas SLHG's P/E ratio is -1.48. In terms of profitability, NUTX's ROE is +0.52%, compared to SLHG's ROE of N/A. Regarding short-term risk, NUTX is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for NUTX.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
NUTX vs AFAM Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas AFAM's P/E ratio is N/A. In terms of profitability, NUTX's ROE is +0.52%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, NUTX is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check AFAM's competition here
Kindred Healthcare, Inc. (NYSE: KND)
NUTX vs KND Comparison August 2026
Nutex Health, Inc. (NASDAQ: NUTX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUTX stands at 1.3B. In comparison, KND has a market cap of 0. Regarding current trading prices, NUTX is priced at $187.42 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUTX currently has a P/E ratio of 14.48, whereas KND's P/E ratio is -1.14. In terms of profitability, NUTX's ROE is +0.52%, compared to KND's ROE of -0.53%. Regarding short-term risk, NUTX is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for NUTX.Check KND's competition here